Retinal Repair Following Inherited and Age-Associated Degeneration
Dr. Lamba leads an NIH-funded laboratory focused on using human stem cells for retinal repair following inherited and age-associated degeneration. He utilizes stem cell technologies to generate disease-in-a-dish models or for cell replacement. The key research interests include (1) exploring the potential and challenges in retinal cell replacement therapies esp. the role of the tissue microenvironment and (2) developing stem-cell based model systems to understand various human retinal degenerations and identifying new therapeutic avenues including genome editing technologies like CRISPR. Dr. Lamba is a natural collaborator with clinician-scientists and since joining the Department in 2018 he has established collaborations with Drs. Jacque Duncan and Tony Moore. Dr. Lamba has mentored numerous pre- and postdoctorates and is also a member of the education committee. His group will provide opportunities for Scholars interested in harnessing the power of novel stem cell technologies to clinical problems especially retinal degenerations.
To Learn More:
Gene Therapy, Retinitis Pigmentosa or Retinal Degenerations, Stem Cell Research, Leber Congenital Amaurosis, Retinal Development, Pluripotent stem cells, Cell replacement
Learn more about UCSF Ophthalmology faculty research.